MAA
ICPT

Managed Account Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Managed Account Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$42.1M Buy
174,549
+78,689
+82% +$21M 0.03% 457
2015
Q1 		$27M Buy
95,860
+92,535
+2,783% +$20M 0.02% 598
2014
Q4 		$519K Buy
3,325
+1,163
+54% +$215K ﹤0.01% 2197
2014
Q3 		$512K Sell
2,162
-3,137
-59% -$800K ﹤0.01% 2173
2014
Q2 		$1.25M Buy
5,299
+3,613
+214% +$952K ﹤0.01% 1951
2014
Q1 		$556K Buy
+1,686
New +$569K ﹤0.01% 2079

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Managed Account Advisors's ICPT Position: Q2 2015 in Review

Managed Account Advisors increased its Intercept Pharmaceuticals, Inc. (ICPT) stake by 82% in Q2 2015, buying an estimated $21M and bringing the position to 174,549 shares worth $42.1M. The position accounts for 0.03% of the portfolio, ranked #457.

Managed Account Advisors first reported a position in ICPT in Q1 2014 and has held it in 6 quarters since. 191 funds tracked by Wall St. Rank hold ICPT as of Q2 2015.

  • Managed Account Advisors held 174,549 shares of Intercept Pharmaceuticals, Inc. worth $42.1M as of Q2 2015.
  • Managed Account Advisors bought 78,689 Intercept Pharmaceuticals, Inc. shares in Q2 2015, an estimated $21M.
  • Intercept Pharmaceuticals, Inc. made up 0.03% of Managed Account Advisors's portfolio in Q2 2015, its #457 holding.
  • Managed Account Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and has held it in 6 quarters since.
  • 191 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.